Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Qiagen (QGEN – Research Report), Sangamo Biosciences (SGMO – Research Report) and Siemens Healthineers AG (SEMHF – Research Report).
Qiagen (QGEN)
In a report released today, Peter Welford from Jefferies maintained a Hold rating on Qiagen, with a price target of EUR42.00. The company’s shares closed last Monday at $41.93, close to its 52-week low of $40.38.
According to TipRanks.com, Welford is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Qiagen with a $48.44 average price target, a 14.3% upside from current levels. In a report issued on October 24, Kepler Capital also maintained a Hold rating on the stock with a EUR50.00 price target.
See the top stocks recommended by analysts >>
Sangamo Biosciences (SGMO)
Wells Fargo analyst Yanan Zhu maintained a Buy rating on Sangamo Biosciences yesterday and set a price target of $20.00. The company’s shares closed last Monday at $3.39, close to its 52-week low of $3.12.
According to TipRanks.com, Zhu ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Sangamo Biosciences is a Moderate Buy with an average price target of $14.50, implying a 297.3% upside from current levels. In a report issued on November 4, RBC Capital also maintained a Buy rating on the stock with a $22.00 price target.
Siemens Healthineers AG (SEMHF)
Berenberg Bank analyst Odysseas Manesiotis maintained a Buy rating on Siemens Healthineers AG today and set a price target of EUR54.00. The company’s shares closed last Monday at $46.94.
According to TipRanks.com, Manesiotis is ranked #7601 out of 8026 analysts.
Currently, the analyst consensus on Siemens Healthineers AG is a Strong Buy with an average price target of $58.97, which is a 25.6% upside from current levels. In a report issued on October 27, Kepler Capital also maintained a Buy rating on the stock with a EUR55.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on QGEN:
